Verrica Pharmaceuticals Inc.
NASDAQ:VRCA · NASDAQ Global Market
-$0.02 today
Vol 0.03M · Avg 0.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-4.09%
Period High
$9.10
Period Low
$3.28
Latest
$5.63
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Q32 Bio Inc.
NASDAQ:QTTB
$156.63M
AN2 Therapeutics, Inc.
NASDAQ:ANTX
$135.91M
SAB Biotherapeutics, Inc.
SABS
$37.95M
Generation Bio Co.
GBIO
$35.98M
Mural Oncology plc
MURA
$35.38M
Boundless Bio, Inc.
BOLD
$32.01M
Evaxion Biotech A/S
EVAX
$20.34M
Plus Therapeutics, Inc.
PSTV
$10.30M
Jasper Therapeutics, Inc.
JSPR
$7.29M
NextCure, Inc.
NXTC
$5.41M
What is the latest VRCA filing?
The latest filing shown is 4 dated Jun 9, 2026.
How many recent filings does VRCA have?
Intrinsic Alpha currently shows 20 recent filings for VRCA.
Explore More
Continue the stock analysis
Jump to another research area for this company.